Ethical Considerations in Conducting Pediatric Research-Reference-Cited by-同舟云学术

Ethical Considerations in Conducting Pediatric Research

Published:2011 Issue: Volume: Page:219-244
ISSN:0171-2004
Container-title:Pediatric Clinical Pharmacology
language:
Short-container-title:

Author:

Roth-Cline Michelle,Gerson Jason,Bright Patricia,Lee Catherine S.,Nelson Robert M.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-20195-0_11.pdf

Reference79 articles.

1. CFR 50, Subpart D. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50&showFR=1&subpartNode=21:1.0.1.1.19.4 . Accessed 3 Jan 2011

2. CFR 50.3(k). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.3 . Accessed 3 Jan 2011

3. CFR 50.3(n). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.3 . Accessed 3 Jan 2011

4. CFR 50.3(o). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.3 . Accessed 3 Jan 2011

5. CFR 50.24. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24 . Accessed 3 Jan 2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small patients, big challenges: navigating the complex world of pediatric reference intervals;Revista Romana de Medicina de Laborator;2024-07-01

2. Conducting Drug Treatment Trials in Children: Opportunities and Challenges;Pharmaceutical Medicine;2024-05

3. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics;Therapeutic Innovation & Regulatory Science;2024-04-23

4. Pediatric Market Access: A Qualitative Study;Therapeutic Innovation & Regulatory Science;2024-01-03

5. An evolutionary algorithm for the direct optimization of covariate balance between nonrandomized populations;Pharmaceutical Statistics;2023-12-18